| 16611122
|
Current status of anti-picornavirus therapies. |
Curr Pharm Des |
2006 |
Barnard DL |
View
More |
| 2559655
|
In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug. |
Antimicrob Agents Chemother |
1989 |
Woods MG;Diana GD;Rogge MC;Otto MJ;Dutko FJ;McKinlay MA |
View
More |
| 29024767
|
Modulation of proteolytic polyprotein processing by coxsackievirus mutants resistant to inhibitors targeting phosphatidylinositol-4-kinase IIIbeta or oxysterol binding protein. |
Antiviral Res |
2017 |
Lyoo H;Dorobantu CM;van der Schaar HM;van Kuppeveld FJM |
View
More |
| 3005578
|
Antipicornavirus activity of substituted phenoxybenzenes and phenoxypyridines. |
J Med Chem |
1986 |
Markley LD;Tong YC;Dulworth JK;Steward DL;Goralski CT;Johnston H;Wood SG;Vinogradoff AP;Bargar TM |
View
More |
| 32231022
|
Antiviral Effects of Menthol on Coxsackievirus B. |
Viruses |
2020 |
Taylor DJR;Hamid SM;Andres AM;Saadaeijahromi H;Piplani H;Germano JF;Song Y;Sawaged S;Feuer R;Pandol SJ;Sin J |
View
More |
| 37156267
|
Anisomycin inhibits Coxsackievirus B replication by promoting the lysosomal degradation of eEF1A1. |
Antiviral Res |
2023 |
Shao E;Zhao S;Dong Y;Wang Y;Fei Y;Li S;Wang L;Bashir T;Luan T;Lin L;Wang Y;Zhao W;Zhong Z |
View
More |
